The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Circulating Exosomal microRNAs as Biomarkers of Colon Cancer
Open accessAbstract
PURPOSE: Exosomal microRNAs (miRNAs) have been attracting major interest as potential diagnostic biomarkers of cancer. The aim of this study was to characterize the miRNA profiles of serum exosomes and to identify those that are altered in colorectal cancer (CRC). To evaluate their use as diagnostic biomarkers, the relationship between specific exosomal miRNA levels and pathological changes of patients, including disease stage and tumor resection, was examined. EXPERIMENTAL DESIGN: Microarray analyses of miRNAs in exosome-enriched fractions of serum samples from 88 primary CRC patients and 11 healthy controls were performed. The expression levels of miRNAs in the culture medium of five colon cancer cell lines were also compared with those in the culture medium of a normal colon-derived cell line. The expression profiles of miRNAs that were differentially expressed between CRC and control sample sets were verified using 29 paired samples from post-tumor resection patients. The sensitivities of selected miRNAs as biomarkers of CRC were evaluated and compared with those of known tumor markers (CA19-9 and CEA) using a receiver operating characteristic analysis. The expression levels of selected miRNAs were also validated by quantitative real-time RT-PCR analyses of an independent set of 13 CRC patients. RESULTS: The serum exosomal levels of seven miRNAs (let-7a, miR-1229, miR-1246, miR-150, miR-21, miR-223, and miR-23a) were significantly higher in primary CRC patients, even those with early stage disease, than in healthy controls, and were significantly down-regulated after surgical resection of tumors. These miRNAs were also secreted at significantly higher levels by colon cancer cell lines than by a normal colon-derived cell line. The high sensitivities of the seven selected exosomal miRNAs were confirmed by a receiver operating characteristic analysis. CONCLUSION: Exosomal miRNA signatures appear to mirror pathological changes of CRC patients and several miRNAs are promising biomarkers for non-invasive diagnosis of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“microRNA's presence in exosomes have been already reported in different cells and cancer types (44–50).”
From Potential Therapeutic Effects of Exosomes Packed With a miR-21-Sponge Construct in a Rat Model of Glioblastoma (2019) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gerçel-Taylor, Ç. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,333
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,077
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
MicroRNA expression profiles classify human cancers
Lü, J., Getz, G. A., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,637
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Causes and consequences of microRNA dysregulation in cancer
Croce, C. M. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2634 · Cited by 3,039
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
Iorio, M. V., & Croce, C. M. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100209 · Cited by 1,778
Atkin, W. S., Edwards, R., Kralj‐Hans, I., Wooldrage, K., Hart, A. R., Northover, J. M. A., Parkin, D. M., Wardle, J., Duffy, S. W., & Cuzick, J. M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60551-x · Cited by 1,618
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 810
A Comprehensive Meta-Analysis of MicroRNAs for Predicting Colorectal Cancer
Lin, Y., Zhao, W., Yu, H., Wang, Y., Liu, Y., & Xie, C. L. (2016) · Medicine · doi:10.1097/md.0000000000002738 · Cited by 28
Galoș, D., Gorzo, A., Bălăcescu, O., & Sur, D. G. (2022) · Cells · doi:10.3390/cells11213493 · Cited by 28
Circulating Exosomal miRNAs as a Promising Diagnostic Biomarker in Cancer
Behulová, R., Bugalová, A., Bugala, J., Struhárňanská, E., Šafranek, M., & Juráš, I. (2023) · Physiological Research · doi:10.33549/physiolres.935153 · Cited by 31
Extracellular vesicles: biogenesis mechanism and impacts on tumor immune microenvironment
Yeat, N. Y., & Chen, R. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01182-2 · Cited by 32
Weng, W., Feng, J., Qin, H., Ma, Y., & Goel, A. (2015) · Future Oncology · doi:10.2217/fon.15.83 · Cited by 28
SACMDA: MiRNA-Disease Association Prediction with Short Acyclic Connections in Heterogeneous Graph
Shao, B., Liu, B., & Yan, C. C. (2018) · Neuroinformatics · doi:10.1007/s12021-018-9373-1 · Cited by 27
Extracellular Vesicles: Novel Opportunities to Understand and Detect Neoplastic Diseases
Bongiovanni, L., Andriessen, A., Wauben, M. H. M., Hoen, E. N. M. N., & de Bruin, A. (2021) · Veterinary Pathology · doi:10.1177/0300985821999328 · Cited by 27
A systematic approach to RNA-associated motif discovery
Gao, T. X., Shu, J., & Cui, J. (2018) · BMC Genomics · doi:10.1186/s12864-018-4528-x · Cited by 26
Exosomal miR-1246 in Body Fluids is a Potential Biomarker for Gastrointestinal Cancer
Wei, C., Li, Y., Huang, K., Li, G., & He, M. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0440 · Cited by 27
MicroRNA-8073: Tumor suppressor and potential therapeutic treatment
Mizoguchi, A., Takayama, A., Arai, T., Kawauchi, J., & Sudo, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0209750 · Cited by 28
Payervand, N., Pakravan, K., Razmara, E., Vinu, K. K., Ghodsi, S., Heshmati, M., & Babashah, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e31584 · Cited by 26
Chung, J., Xiao, S., Gao, Y., & Soung, Y. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168703 · Cited by 26
Clinical value of microRNA-23a upregulation in non-small cell lung cancer.
Qu, W., Liu, L., & Yu, Z. (2015) · Europe PMC (PubMed Central) · Cited by 26
Dual Laplacian regularized matrix completion for microRNA-disease associations prediction
Tang, C., Zhou, H., Zheng, X., Zhang, Y., & Sha, X. (2019) · RNA Biology · doi:10.1080/15476286.2019.1570811 · Cited by 26
Serum microRNA‑125a‑5p as a potential biomarker of HCV‑associated hepatocellular carcinoma
Oura, K., Fujita, K., Morishita, A., Iwama, H., Nakahara, M., Tadokoro, T., Sakamoto, T., Nomura, T., Yoneyama, H., Mimura, S., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10385 · Cited by 26
Ahmadi, M., Jafari, R., Mahmoodi, M., & Rezaie, J. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3622 · Cited by 26
MiRNA-Disease association prediction via non-negative matrix factorization based matrix completion
Zheng, X., Zhang, C., & Cheng, W. (2021) · Signal Processing · doi:10.1016/j.sigpro.2021.108312 · Cited by 26
Onukwugha, N., Kang, Y., & Nagrath, S. (2022) · Lab on a Chip · doi:10.1039/d2lc00232a · Cited by 24
The Rise of Extracellular Vesicles as New Age Biomarkers in Cancer Diagnosis: Promises and Pitfalls
Bamankar, S., & Londhe, V. Y. (2023) · Technology in Cancer Research & Treatment · doi:10.1177/15330338221149266 · Cited by 26
Fusion of Exosomes and Nanotechnology: Cutting-Edge Cancer Theranostics
Agnihotram, R., Dhar, R., Dhar, D., Purushothaman, K., Narasimhan, A. K., & Devi, A. (2024) · ACS Applied Nano Materials · doi:10.1021/acsanm.4c01033 · Cited by 27
Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients
Farace, C., Pisano, A., Griñán‐Lisón, C., Solinas, G., Jiménez, G., Serra, M., Carrillo, E., Scognamillo, F., Attene, F., Montella, A., et al. (2020) · Oncotarget · doi:10.18632/oncotarget.27411 · Cited by 26
Pathogenesis and biomarkers of colorectal cancer by epigenetic alteration
Oh, C. K., & Cho, Y. (2024) · Intestinal Research · doi:10.5217/ir.2023.00115 · Cited by 24
Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis
Ždralević, M., Radović, A., Raonić, J., Popović, N., Klisic, A. N., & Vučković, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252011060 · Cited by 28
Further the liquid biopsy: Gathering pieces of the puzzle of genometastasis theory
García‐Casas, A., Garcı́a-Olmo, D. C., & García‐Olmo, D. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i5.378 · Cited by 25
Huang, Q., Hsueh, C., Guo, Y., Wu, X., Li, J.-Y., & Zhou, L. F. (2020) · IUBMB Life · doi:10.1002/iub.2274 · Cited by 25
Sur, D. G., Bălăcescu, L., Cainap, S. S., Vișan, S., Pop, L., Burz, C. C., Havasi, A. D., Buiga, R., Cainap, C. I., Irimie, A., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.651380 · Cited by 25
Li, Y., Zhang, J., Li, S., Guo, C., Li, Q., Zhang, X., Li, M., & Mi, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.687912 · Cited by 26
Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression
Bakhsh, T., Alhazmi, S., Alburae, N. A., Farsi, A., Alzahrani, F. A., Choudhry, H., & Bahieldin, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094855 · Cited by 26
Exosomes in Colorectal Cancer: From Physiology to Clinical Applications
Țîțu, Ș., Gâta, V., Decea, R., Mocan, T., Dina, C., Irimie, A., & Lisencu, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054382 · Cited by 24
Exosomes as Biomarker of Cancer
Sumrin, A., Moazzam, S., Khan, A. A., Ramzan, I., Batool, Z., Kaleem, S., Ali, M., Bashir, H., & Bilal, M. (2018) · Brazilian Archives of Biology and Technology · doi:10.1590/1678-4324-2018160730 · Cited by 27
MicroRNAs in diagnosis and therapeutics
Atri, C., Guerfali, F. Z., & Laouini, D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00006-3 · Cited by 25
Zhu, X., Wang, R., Zhou, X., & Shi, H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06579 · Cited by 24
Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers
Karin‐Kujundžić, V., Šola, I. M., Predavec, N., Potkonjak, A., Somen, E., Mioč, P., Šerman, A., Vranić, S., & Šerman, L. (2019) · Cells · doi:10.3390/cells8111459 · Cited by 25
Crow, J., Samuel, G., & Godwin, A. K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1688144 · Cited by 24
EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC
Słomka, A., Mocan, T., Wang, B., Nenu, I., Urban, S., Gonzalez-Carmona, M. A., Schmidt‐Wolf, I. G. H., Kornek, M., Strassburg, C., Sparchez, Z. A., et al. (2020) · Cancers · doi:10.3390/cancers12103019 · Cited by 24
Exosomal Components and Modulators in Colorectal Cancer: Novel Diagnosis and Prognosis Biomarkers
Chang, Y., Chan, M., Li, C., Fang, C., Hsiao, M., & Chen, C. (2021) · Biomedicines · doi:10.3390/biomedicines9080931 · Cited by 25
Chang, L., Chiu, H., Wu, M., & Shen, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031379 · Cited by 24
Diagnostic Potential of Exosomal microRNAs in Colorectal Cancer
Dohmen, J., Semaan, A., Kobilay, M., Zaleski, M., Branchi, V., Schlierf, A., Hettwer, K., Uhlig, S., Hartmann, G., Kalff, J. C., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12061413 · Cited by 24
Liquid biopsy in colorectal cancer
Najafi, S., Majidpoor, J., & Mortezaee, K. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117674 · Cited by 27
Genome-wide miRNA response to anacardic acid in breast cancer cells
Schultz, D. J., Muluhngwi, P., Alizadeh‐Rad, N., Green, M. A., Rouchka, E. C., Waigel, S. J., & Klinge, C. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184471 · Cited by 24
microRNA-25 as a novel modulator of circadian Period2 gene oscillation
Park, I., Kim, D., Kim, J., Jang, S., Choi, M., Choe, H. K., Choe, Y., & Kim, K. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00496-5 · Cited by 25
Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4
Ono, R., Yoshioka, Y., Furukawa, Y., Naruse, M., Kuwagata, M., Ochiya, T., Kitajima, S., & Hirabayashi, Y. (2020) · Toxicology Reports · doi:10.1016/j.toxrep.2020.05.002 · Cited by 24
Zhu, Y., Yang, T., Wu, Q., Yang, X., Hao, J., Deng, X., Yang, S., Gu, C., & Wang, Z. (2020) · Cancer Medicine · doi:10.1002/cam4.3276 · Cited by 23
Grabia, S., Smyczyńska, U., Pagacz, K., & Fendler, W. M. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03743-8 · Cited by 25
DF-MDA: An effective diffusion-based computational model for predicting miRNA-disease association
Li, H., You, Z., Wang, L., Yan, X., & Li, Z. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.003 · Cited by 23
Jorgensen, B. G., & Ro, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042166 · Cited by 24
Exosomes as a Source of Biomarkers for Gastrointestinal Cancers
Yu, J., Ostowari, A., Gonda, A., Mashayekhi, K., Dayyani, F., Hughes, C. C. W., & Senthil, M. (2023) · Cancers · doi:10.3390/cancers15041263 · Cited by 23
Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer
Li, T., Zhou, T., Wu, J., Lv, H., Zhou, H., Du, M., Zhang, X., Wu, N., Gong, S., Ren, Z., et al. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101652 · Cited by 23
The Diagnostic Power of Circulating miR-1246 in Screening Cancer: An Updated Meta-analysis
Khanh, H. Q., Le, A. T., Phan, T. T., Ho, T. T., Pho, S. P., Nguyen, H. T., Anh, L. T., Nguyen, T. T., & Nguyen, S. T. (2023) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2023/8379231 · Cited by 22
Peng, Z., & Zhang, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.6061 · Cited by 23
Makondi, P. T., Wei, P., Huang, C., & Chang, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211968 · Cited by 23
Mehta, M. J., Shin, D., Park, H. S., An, J., Lim, S. I., Kim, H. J., Hong, S., & Bu, J. (2025) · Small Methods · doi:10.1002/smtd.202402058 · Cited by 25
Recent advances in extracellular vesicles enriched with non-coding RNAs related to cancers
Song, Y., & Li, X. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.12.001 · Cited by 23
Morita, T., Fujiwara, T., Yoshida, A., Uotani, K., Kiyono, M., Yokoo, S., Hasei, J., Kunisada, T., & Ozaki, T. (2020) · Scientific Reports · doi:10.1038/s41598-020-66120-8 · Cited by 24
Marín-Romero, A., Tabraue-Chávez, M., Dear, J. W., Sanchez-Martin, R. M., Ilyine, H., Guardia-Monteagudo, J. J., Fara, M. A., López‐Delgado, F. J., Díaz‐Mochon, J. J., & Pernagallo, S. (2020) · Talanta · doi:10.1016/j.talanta.2020.121265 · Cited by 23
Exosomal noncoding RNAs in colorectal cancer
Wu, Q., Liu, W., Wang, J., Zhu, L., Wang, Z., & Peng, Y. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.08.037 · Cited by 22
Huang, Y., Huang, T., Yadav, V. K., Sumitra, M. R., Tzeng, D. T. W., Wei, P., Shih, J.-W., & Wu, A. T. H. (2020) · PubMed Central · Cited by 22
Piffoux, M., Volatron, J., Silva, A., & Gazeau, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111931 · Cited by 24
Pawełka, D., Łaczmańska, I., Karpiński, P., Supplitt, S., Witkiewicz, W., Knychalski, B., PELAK, J., Żebrowska-Różańska, P., & Łaczmański, Ł. (2022) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20336 · Cited by 22
The Exosome Journey: From Biogenesis to Regulation and Function in Cancers
Li, Y., Li, M., Li, B., Li, Y., Shen, T., & Zhao, B. (2022) · Journal of Oncology · doi:10.1155/2022/9356807 · Cited by 26
Kwok, Z. H., Zhang, B., Chew, X. H., Chan, J. J., Teh, V., Yang, H. H., Kappei, D., & Tay, Y. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1406 · Cited by 22
Extracellular vesicles in cancer pros and cons: The importance of the evidence-based medicine
Cappello, F., & Fais, S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.01.011 · Cited by 23
Dabral, P., Bhasin, N., Ranjan, M., Makhlouf, M. M., & Elmageed, Z. Y. A. (2024) · Cancers · doi:10.3390/cancers16132462 · Cited by 24
Circulating microRNAs: Next-generation Cancer Detection
Matsuzaki, J., & Ochiya, T. (2020) · The Keio Journal of Medicine · doi:10.2302/kjm.2019-0011-oa · Cited by 21
Exosomes in Dogs and Cats: An Innovative Approach to Neoplastic and Non-Neoplastic Diseases
Diomaiuto, E., Principe, V., Luca, A. D., Laperuta, F., Alterisio, M. C., & Loria, A. D. (2021) · Pharmaceuticals · doi:10.3390/ph14080766 · Cited by 21
Shao, Y., Wang, Q., Liu, L., Wang, J., & Wu, M. (2022) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.2022.j118 · Cited by 21
Wu, L., Xue, M., Lai, S., Chen, J., Lin, Y., Ding, N., Zhong, J., Chen, S., & Wang, L. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121872 · Cited by 21
A brief review of exosomes and their roles in cancer
Mollaei, H., Safaralizadeh, R., & Pouladi, N. (2016) · Meta Gene · doi:10.1016/j.mgene.2016.11.010 · Cited by 23
Ahmed, E. K., Fahmy, S. A., Effat, H., & Wahab, A. H. A. A. (2018) · Journal of Medical Biochemistry · doi:10.2478/jomb-2018-0010 · Cited by 21
Exosome-Derived microRNA: Efficacy in Cancer
Padda, J., Khalid, K., Khedr, A., Patel, V., Al-Ewaidat, O. A., Tasnim, F., Padda, S., Cooper, A. C., & Jean-Charles, G. (2021) · Cureus · doi:10.7759/cureus.17441 · Cited by 23
MiR-1246 is upregulated and regulates lung cell apoptosis during heat stress in feedlot cattle
Hu, Y. X., Cai, M., Wang, L., Zhang, T.-H., Luo, Z.-G., Zhang, G., & Zuo, F. (2018) · Cell Stress and Chaperones · doi:10.1007/s12192-018-0927-9 · Cited by 20
Extracellular Vesicles for the Diagnosis of Cancers
Xue, Y., Feng, X., Fan, X., Zhu, G., McLaughlan, J. R., Zhang, W., & Chen, X. (2021) · Small Structures · doi:10.1002/sstr.202100096 · Cited by 20
The Role of ncRNAs in the Immune Dysregulation of Preeclampsia
Mora-Palazuelos, C. E., Villegas‐Mercado, C. E., Avendaño-Félix, M. M., Lizárraga-Verdugo, E. R., Romero-Quintana, J. G., López-Gutiérrez, J., Beltrán-Ontiveros, S. A., & Bermúdez, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015215 · Cited by 20
Feng, Y., Jin, C., Wang, T., Chen, Z., Ji, D., Zhang, Y., Zhang, C., Zhang, D., Peng, W., & Sun, Y. (2024) · Advanced Science · doi:10.1002/advs.202304222 · Cited by 20
Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective
Manne, U., Jadhav, T., Putcha, B. K., Samuel, T., Soni, S., Shanmugam, C., & Suswam, E. A. (2016) · Current Colorectal Cancer Reports · doi:10.1007/s11888-016-0338-1 · Cited by 20
The immunomodulatory role of tumor‐derived extracellular vesicles in colorectal cancer
Manning, S., & Danielson, K. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12038 · Cited by 20
Xu, F., Xu, L., Wang, M., An, G., & Feng, G. (2015) · Colorectal Disease · doi:10.1111/codi.12917 · Cited by 20
Shi, X., Zhao, X., Xue, J., & Jia, E. (2024) · BMC Cancer · doi:10.1186/s12885-024-12312-8 · Cited by 23
miR clusters target cellular functional complexes by defining their degree of regulatory freedom
Haier, J., Ströse, A., Matuszcak, C., & Hummel, R. (2016) · Cancer and Metastasis Reviews · doi:10.1007/s10555-016-9617-1 · Cited by 19
Emerging Role of Extracellular Vesicles in Biomarking the Gastrointestinal Diseases
Heydari, R., Abdollahpour‐Alitappeh, M., Shekari, F., & Meyfour, A. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1954909 · Cited by 21
Hao, Y.-J., Yang, C., Chen, M., Chang, L.-W., Lin, C., Lo, L., Huang, S., Lyu, Y.-Y., Jiang, J., & Tseng, F. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092400 · Cited by 19
Ferlizza, E., Romaniello, D., Borrelli, F., Pagano, F., Girone, C., Gelfo, V., Kuhre, R. S., Morselli, A., Mazzeschi, M., Sgarzi, M., et al. (2023) · Cancers · doi:10.3390/cancers15112970 · Cited by 19
Horizontal Transfer of Malignant Traits and the Involvement of Extracellular Vesicles in Metastasis
Arena, G. O., Forte, S., Abdouh, M., Vanier, C. H., Corbeil, D., & Lorico, A. (2023) · Cells · doi:10.3390/cells12121566 · Cited by 18
Marassi, V., Giordani, S., Placci, A., Punzo, A., Caliceti, C., Zattoni, A., Reschiglian, P., Roda, B., & Roda, A. (2023) · Sensors · doi:10.3390/s23239432 · Cited by 20
Consensus statement on extracellular vesicles in liquid biopsy for advancing laboratory medicine
Dong, X., Lin, Y., Li, K., Liang, G., Huang, X., Pan, J., Wang, L., Zhang, D., Liu, T., Wang, T., et al. (2024) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2024-0188 · Cited by 20
Therapeutic and diagnostic applications of exosomes in colorectal cancer
Shakerian, N., Eslam, E. D., Afsharnoori, F., Bana, N., ghahroodi, F. N., Tarin, M., Mard‐Soltani, M., Khalesi, B., Hashemi, Z. S., & Khalili, S. (2024) · Medical Oncology · doi:10.1007/s12032-024-02440-3 · Cited by 21
Tumor-derived exosomes in cancer metastasis risk diagnosis and metastasis therapy
Jiang, S., Hu, C., Liu, P., & Lu, M. (2018) · Clinical & Translational Oncology · doi:10.1007/s12094-018-1918-0 · Cited by 19
Hayashi, M., Kuroda, K., Ihara, K., Iwaya, T., & Isogai, E. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3875 · Cited by 19
Ishiguro, Y., 崎浜, 秀., Yoshida, T., Ichikawa, N., Homma, S., Fukai, M., Kawamura, H., Takahashi, N., & Taketomi, A. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08827-6 · Cited by 19
Sattar, R. S. A., Verma, R., Nimisha, Kumar, A., Dar, G. M., Apurva, A., Sharma, A. K., Kumari, I., Ahmad, E., Ali, A., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110413 · Cited by 18
Towards the realization of clinical extracellular vesicle diagnostics: challenges and opportunities
Yokoi, A., Yoshioka, Y., & Ochiya, T. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.1104249 · Cited by 19
MicroRNAs as potential drug targets for therapeutic intervention in colorectal cancer
Jafri, M., Zaidi, S. K., Ansari, S. A., Al-Qahtani, M. H., & Shay, J. W. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1069816 · Cited by 18
Bookland, M. J., Tang‐Schomer, M. D., Gillan, E., & Kolmakova, A. (2018) · Acta Neurochirurgica · doi:10.1007/s00701-018-3589-6 · Cited by 18
The diagnostic value of exosomal miRNAs in human bile of malignant biliary obstructions
Ge, X., Tang, L., Wang, Y., Wang, N., Zhou, J., Deng, X., Zhong, Y., Li, Q., Wang, F., Jiang, G., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.11.010 · Cited by 18
Development and Clinical Application of Tumor-derived Exosomes in Patients with Cancer
Verdi, J., Ketabchi, N., Noorbakhsh, N., Saleh, M., Ebrahimi‐Barough, S., Seyhoun, I., & Kavianpour, M. (2021) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x16666210622123942 · Cited by 17
Yoshikawa, Y., Fukunaga, M., Takahashi, J., Shimizu, D., Masuda, T., Mizushima, T., Yamada, K., Mori, M., Eguchi, H., Doki, Y., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12355-w · Cited by 17
Exosomal miRNAs as novel avenues for breast cancer treatment
Singh, T., Kaushik, M. C., Mishra, L. C., Behl, C., Singh, V. P., & Tuli, H. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1134779 · Cited by 17
The Detection of Urinary Exosomal miRNAs for Cancer Diagnostics and Prognostics
Kim, J., Kim, M., Kang, J. Y., Bong, K. W., & Choi, N. (2023) · BioChip Journal · doi:10.1007/s13206-023-00108-0 · Cited by 17
Wang, S., Wang, J., Wei, W., & Ma, G. (2019) · Advanced Biosystems · doi:10.1002/adbi.201900008 · Cited by 17
Serum exosomal miRNA as biomarkers for Retinoblastoma
Ravishankar, H., Mangani, A. S., Moses, G. L. P., Mani, S. P., Parameswaran, S., Khetan, V., Ganesan, S., & Krishnakumar, S. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108184 · Cited by 17
Metadata
- Authors
- Ogata-Kawata, H., Izumiya, M., Kurioka, D., Honma, Y., Yamada, Y., Furuta, K., Gunji, T., Ohta, H., Okamoto, H., Sonoda, H., Watanabe, M., Nakagama, H., Yokota, J., Kohno, T., & Tsuchiya, N.
- Affiliations
- University of Tokyo Hospital (JP)
- Yokohama National University (JP)
- National Cancer Center Hospital (JP)
- NTT Medical Center (JP)
- Shionogi (Japan) (JP)
- National Cancer Center Research Institute (JP)
- Institute of Predictive and Personalized Medicine of Cancer (ES)
- Corresponding author
- Tsuchiya, Naoto
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-04-04
- Volume
- 9
- Issue
- 4
- Pages
- e92921
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3976275
- OpenAlex
- W1992970284
- Cited by
- 809
- References
- 37
- Citations by year
- 2026: 28 · 2025: 37 · 2024: 51 · 2023: 45 · 2022: 76 · 2021: 96 · 2020: 89 · 2019: 81 · 2018: 76 · 2017: 76 · 2016: 78 · 2015: 60 · 2014: 15
- FWCI
- 31.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Biomedical Innovation
- Japan Society for the Promotion of Science (23300359, 24790683)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Keywords
- exosomal microRNAs, colorectal cancer, serum exosomes, diagnostic biomarkers, non-invasive diagnosis, miR-21, miR-223, miR-23a, miR-150, miR-1246, let-7a, tumor resection, CA19-9, carcinoembryonic antigen
- MeSH terms
- Adult, Aged, Colonic Neoplasms, Female, Humans, Male, Middle Aged, Tumor Cells, Cultured, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Case-Control Studies, HT29 Cells, Gene Expression Profiling, MicroRNAs, HCT116 Cells, Cell Line, Tumor, Microarray Analysis, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review